Pulmonx
Carolynn P. is an experienced professional in document control and quality assurance with a strong background in the healthcare and medical device industries. Currently serving as a Document Control Specialist IV at Pulmonx Corporation since June 2022, Carolynn previously held roles including Document Control at Motiv Power Systems and several key positions at SGS, where responsibilities included supporting new business targeting healthcare clients and managing multidisciplinary teams servicing Fortune 500 companies. Additionally, Carolynn has significant experience in operations and project management within the global packaging and labeling sector at companies such as Schawk! and LifeScan, Johnson & Johnson. Carolynn's educational background includes a Bachelor of Arts in Political Science from the University of California, Berkeley.
This person is not in any teams
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1